VER-Net: a hybrid transfer learning model for lung cancer detection using CT scan images.

BACKGROUND: Lung cancer is the second most common cancer worldwide, with over two million new cases per year. Early identification would allow healthcare practitioners to handle it more effectively. The advancement of computer-aided detection systems significantly impacted clinical analysis and decision-making on human disease. Towards this, machine learning and deep learning techniques are successfully being applied. Due to several advantages, transfer learning has become popular for disease detection based on image data. METHODS: In this work, we build a novel transfer learning model (VER-Net) by stacking three different transfer learning models to detect lung cancer using lung CT scan images. The model is trained to map the CT scan images with four lung cancer classes. Various measures, such as image preprocessing, data augmentation, and hyperparameter tuning, are taken to improve the efficacy of VER-Net. All the models are trained and evaluated using multiclass classifications chest CT images. RESULTS: The experimental results confirm that VER-Net outperformed the other eight transfer learning models compared with. VER-Net scored 91%, 92%, 91%, and 91.3% when tested for accuracy, precision, recall, and F1-score, respectively. Compared to the state-of-the-art, VER-Net has better accuracy. CONCLUSION: VER-Net is not only effectively used for lung cancer detection but may also be useful for other diseases for which CT scan images are available.

Explainable lung cancer classification with ensemble transfer learning of VGG16, Resnet50 and InceptionV3 using grad-cam.

Medical imaging stands as a critical component in diagnosing various diseases, where traditional methods often rely on manual interpretation and conventional machine learning techniques. These approaches, while effective, come with inherent limitations such as subjectivity in interpretation and constraints in handling complex image features. This research paper proposes an integrated deep learning approach utilizing pre-trained models-VGG16, ResNet50, and InceptionV3-combined within a unified framework to improve diagnostic accuracy in medical imaging. The method focuses on lung cancer detection using images resized and converted to a uniform format to optimize performance and ensure consistency across datasets. Our proposed model leverages the strengths of each pre-trained network, achieving a high degree of feature extraction and robustness by freezing the early convolutional layers and fine-tuning the deeper layers. Additionally, techniques like SMOTE and Gaussian Blur are applied to address class imbalance, enhancing model training on underrepresented classes. The model's performance was validated on the IQ-OTH/NCCD lung cancer dataset, which was collected from the Iraq-Oncology Teaching Hospital/National Center for Cancer Diseases over a period of three months in fall 2019. The proposed model achieved an accuracy of 98.18%, with precision and recall rates notably high across all classes. This improvement highlights the potential of integrated deep learning systems in medical diagnostics, providing a more accurate, reliable, and efficient means of disease detection.

Wavelet decomposition facilitates training on small datasets for medical image classification by deep learning.

The adoption of low-dose computed tomography (LDCT) as the standard of care for lung cancer screening results in decreased mortality rates in high-risk population while increasing false-positive rate. Convolutional neural networks provide an ideal opportunity to improve malignant nodule detection; however, due to the lack of large adjudicated medical datasets these networks suffer from poor generalizability and overfitting. Using computed tomography images of the thorax from the National Lung Screening Trial (NLST), we compared discrete wavelet transforms (DWTs) against convolutional layers found in a CNN in order to evaluate their ability to classify suspicious lung nodules as either malignant or benign. We explored the use of the DWT as an alternative to the convolutional operations within CNNs in order to decrease the number of parameters to be estimated during training and reduce the risk of overfitting. We found that multi-level DWT performed better than convolutional layers when multiple kernel resolutions were utilized, yielding areas under the receiver-operating curve (AUC) of 94% and 92%, respectively. Furthermore, we found that multi-level DWT reduced the number of network parameters requiring evaluation when compared to a CNN and had a substantially faster convergence rate. We conclude that utilizing multi-level DWT composition in place of early convolutional layers within a DNN may improve for image classification in data-limited domains.

A Machine Learning Approach to Diagnosing Lung and Colon Cancer Using a Deep Learning-Based Classification Framework.

The field of Medicine and Healthcare has attained revolutionary advancements in the last forty years. Within this period, the actual reasons behind numerous diseases were unveiled, novel diagnostic methods were designed, and new medicines were developed. Even after all these achievements, diseases like cancer continue to haunt us since we are still vulnerable to them. Cancer is the second leading cause of death globally; about one in every six people die suffering from it. Among many types of cancers, the lung and colon variants are the most common and deadliest ones. Together, they account for more than 25% of all cancer cases. However, identifying the disease at an early stage significantly improves the chances of survival. Cancer diagnosis can be automated by using the potential of Artificial Intelligence (AI), which allows us to assess more cases in less time and cost. With the help of modern Deep Learning (DL) and Digital Image Processing (DIP) techniques, this paper inscribes a classification framework to differentiate among five types of lung and colon tissues (two benign and three malignant) by analyzing their histopathological images. The acquired results show that the proposed framework can identify cancer tissues with a maximum of 96.33% accuracy. Implementation of this model will help medical professionals to develop an automatic and reliable system capable of identifying various types of lung and colon cancers.

Resectable lung lesions malignancy assessment and cancer detection by ultra-deep sequencing of targeted gene mutations in plasma cell-free DNA.

BACKGROUND: Early detection of lung cancer to allow curative treatment remains challenging. Cell-free circulating tumour (ct) DNA (ctDNA) analysis may aid in malignancy assessment and early cancer diagnosis of lung nodules found in screening imagery. METHODS: The multicentre clinical study enrolled 192 patients with operable occupying lung diseases. Plasma ctDNA, white cell count genomic DNA (gDNA) and tumour tissue gDNA of each patient were analysed by ultra-deep sequencing to an average of 35 000× of the coding regions of 65 lung cancer-related genes. RESULTS: The cohort consists of a quarter of benign lung diseases and three quarters of cancer patients with all histopathology subtypes. 64% of the cancer patients are at stage I. Gene mutations detection in tissue gDNA and plasma ctDNA results in a sensitivity of 91% and specificity of 88%. When ctDNA assay was used as the test, the sensitivity was 69% and specificity 96%. As for the lung cancer patients, the assay detected 63%, 83%, 94% and 100%, for stages I, II, III and IV, respectively. In a linear discriminant analysis, combination of ctDNA, patient age and a panel of serum biomarkers boosted the overall sensitivity to 80% at a specificity of 99%. 29 out of the 65 genes harboured mutations in the patients with lung cancer with the largest number found in TP53 (30% plasma and 62% tumour tissue samples) and EGFR (20% and 40%, respectively). CONCLUSION: Plasma ctDNA was analysed in lung nodule assessment and early cancer detection, while an algorithm combining clinical information enhanced the test performance. TRIAL REGISTRATION NUMBER: NCT03081741.

Enhancement of Classifier Performance with Adam and RanAdam Hyper-Parameter Tuning for Lung Cancer Detection from Microarray Data-In Pursuit of Precision.

Microarray gene expression analysis is a powerful technique used in cancer classification and research to identify and understand gene expression patterns that can differentiate between different cancer types, subtypes, and stages. However, microarray databases are highly redundant, inherently nonlinear, and noisy. Therefore, extracting meaningful information from such a huge database is a challenging one. The paper adopts the Fast Fourier Transform (FFT) and Mixture Model (MM) for dimensionality reduction and utilises the Dragonfly optimisation algorithm as the feature selection technique. The classifiers employed in this research are Nonlinear Regression, Naïve Bayes, Decision Tree, Random Forest and SVM (RBF). The classifiers' performances are analysed with and without feature selection methods. Finally, Adaptive Moment Estimation (Adam) and Random Adaptive Moment Estimation (RanAdam) hyper-parameter tuning techniques are used as improvisation techniques for classifiers. The SVM (RBF) classifier with the Fast Fourier Transform Dimensionality Reduction method and Dragonfly feature selection achieved the highest accuracy of 98.343% with RanAdam hyper-parameter tuning compared to other classifiers.

Hybrid healthcare unit recommendation system using computational techniques with lung cancer segmentation.

Introduction: Our research addresses the critical need for accurate segmentation in medical healthcare applications, particularly in lung nodule detection using Computed Tomography (CT). Our investigation focuses on determining the particle composition of lung nodules, a vital aspect of diagnosis and treatment planning. Methods: Our model was trained and evaluated using several deep learning classifiers on the LUNA-16 dataset, achieving superior performance in terms of the Probabilistic Rand Index (PRI), Variation of Information (VOI), Region of Interest (ROI), Dice Coecient, and Global Consistency Error (GCE). Results: The evaluation demonstrated a high accuracy of 91.76% for parameter estimation, confirming the effectiveness of the proposed approach. Discussion: Our investigation focuses on determining the particle composition of lung nodules, a vital aspect of diagnosis and treatment planning. We proposed a novel segmentation model to identify lung disease from CT scans to achieve this. We proposed a learning architecture that combines U-Net with a Two-parameter logistic distribution for accurate image segmentation; this hybrid model is called U-Net++, leveraging Contrast Limited Adaptive Histogram Equalization (CLAHE) on a 5,000 set of CT scan images.

Advanced hybrid attention-based deep learning network with heuristic algorithm for adaptive CT and PET image fusion in lung cancer detection.

Lung cancer is one of the most deadly diseases in the world. Lung cancer detection can save the patient's life. Despite being the best imaging tool in the medical sector, clinicians find it challenging to interpret and detect cancer from Computed Tomography (CT) scan data. One of the most effective ways for the diagnosis of certain malignancies like lung tumours is Positron Emission Tomography (PET) imaging. So many diagnosis models have been implemented nowadays to diagnose various diseases. Early lung cancer identification is very important for predicting the severity level of lung cancer in cancer patients. To explore the effective model, an image fusion-based detection model is proposed for lung cancer detection using an improved heuristic algorithm of the deep learning model. Firstly, the PET and CT images are gathered from the internet. Further, these two collected images are fused for further process by using the Adaptive Dilated Convolution Neural Network (AD-CNN), in which the hyperparameters are tuned by the Modified Initial Velocity-based Capuchin Search Algorithm (MIV-CapSA). Subsequently, the abnormal regions are segmented by influencing the TransUnet3+. Finally, the segmented images are fed into the Hybrid Attention-based Deep Networks (HADN) model, encompassed with Mobilenet and Shufflenet. Therefore, the effectiveness of the novel detection model is analyzed using various metrics compared with traditional approaches. At last, the outcome evinces that it aids in early basic detection to treat the patients effectively.

Performance evaluation of deep learning techniques for lung cancer prediction.

Due to the increase in pollution, the number of deaths caused by lung disease is rising rapidly. It is essential to predict the disease in earlier stages by means of high-level knowledge and acquaintance. Deep learning-based lung cancer prediction plays a vital role in assisting the medical practioners for diagnosing lung cancer in earlier stage. Computer-Aided diagnosis is considered to bring a boost to the field of medicine by tying it to automated systems. In this research paper, several models are experimented by using chest X-ray image or CT scan as an input to detect a particular disease. This research work is carried out to identify the best performing deep learning techniques for lung disease prediction. The performance of the method is evaluated using various performance metrics, such as precision, recall, accuracy and Jaccard index.

Group theoretic particle swarm optimization for multi-level threshold lung cancer image segmentation.

Background: Image segmentation is an important step during the processing of medical images. For example, for the computer aid diagnostic systems for lung cancer image analysis, the segmented regions of tumors would help doctors in early diagnosis to determine timely and appropriate treatment possibilities and thereby improve the survival rate of the patients. However, general clinical routines of manual segmentation for large number of medical images are very difficult and time consuming, which is the challenge we aim to tackle using our proposed method. Methods: A novel image segmentation method with evolutionary learning technique named Group Theoretic Particle Swarm Optimization is proposed. It can tackle multi-level thresholding optimization problem during the segmentation process and rebuild the search paradigm according to the solid mathematical foundation of symmetric group from four designable aspects, which are particle encoding, solution landscape, neighborhood movement and swarm topology, respectively. The Kapur's entropy of multi-level thresholds is assessed as the objective function. Results: In contrast to those conventional metaheuristics methods for lung cancer image segmentation, this newly presented method generates the best performance result among them. Experimental results show that its Kapur's entropy has the value of 9.07, which is 16% higher than the worst case. Computational time is acceptable at the cost of 173.730 seconds, average level of evaluation metrics [Kappa, Precision, Recall, F1-measure, intersection over union (IoU) and receiver operating characteristic (ROC)] is over 90%, and search process of multi-level threshold combination would finally converge in the later phase of iterations after 700. The ablation study indicates that all components are significant to the contributions of our proposed method. Conclusions: Group Theoretic Particle Swarm Optimization for multi-level threshold segmentation is an efficient way to split a medical image into distinct regions and extract tumor tissues regions from the background. It maintains the balanced relationship between diversification and intensification during the search process and helps clinicians to make the diagnosis more accurately. Our proposed method processes potential medical value and clinical meanings.

Chemiresistive Sensor Array with Nanostructured Interfaces for Detection of Human Breaths with Simulated Lung Cancer Breath VOCs.

Timely screening of lung cancer represents a challenging task for early diagnosis and treatment, which calls for reliable, low-cost, and noninvasive detection tools. One type of promising tools for early-stage cancer detection is breath analyzers or sensors that detect breath volatile organic compounds (VOCs) as biomarkers in exhaled breaths. However, a major challenge is the lack of effective integration of the different sensor system components toward the desired portability, sensitivity, selectivity, and durability for many of the current breath sensors. In this report, we demonstrate herein a portable and wireless breath sensor testing system integrated with sensor electronics, breath sampling, data processing, and sensor arrays derived from nanoparticle-structured chemiresistive sensing interfaces for detection of VOCs relevant to lung cancer biomarkers in human breaths. In addition to showing the sensor viability for the targeted application by theoretical simulations of chemiresistive sensor array responses to the simulated VOCs in human breaths, the sensor system was tested experimentally with different combinations of VOCs and human breath samples spiked with lung cancer-specific VOCs. The sensor array exhibits high sensitivity to lung cancer VOC biomarkers and mixtures, with a limit of detection as low as 6 ppb. The results from testing the sensor array system in detecting breath samples with simulated lung cancer VOC constituents have demonstrated an excellent recognition rate in discriminating healthy human breath samples and those with lung cancer VOCs. The recognition statistics were analyzed, showing the potential viability and optimization toward achieving the desired sensitivity, selectivity, and accuracy in the breath screening of lung cancer.

Optimization System Based on Convolutional Neural Network and Internet of Medical Things for Early Diagnosis of Lung Cancer.

Recently, deep learning and the Internet of Things (IoT) have been widely used in the healthcare monitoring system for decision making. Disease prediction is one of the emerging applications in current practices. In the method described in this paper, lung cancer prediction is implemented using deep learning and IoT, which is a challenging task in computer-aided diagnosis (CAD). Because lung cancer is a dangerous medical disease that must be identified at a higher detection rate, disease-related information is obtained from IoT medical devices and transmitted to the server. The medical data are then processed and classified into two categories, benign and malignant, using a multi-layer CNN (ML-CNN) model. In addition, a particle swarm optimization method is used to improve the learning ability (loss and accuracy). This step uses medical data (CT scan and sensor information) based on the Internet of Medical Things (IoMT). For this purpose, sensor information and image information from IoMT devices and sensors are gathered, and then classification actions are taken. The performance of the proposed technique is compared with well-known existing methods, such as the Support Vector Machine (SVM), probabilistic neural network (PNN), and conventional CNN, in terms of accuracy, precision, sensitivity, specificity, F-score, and computation time. For this purpose, two lung datasets were tested to evaluate the performance: Lung Image Database Consortium (LIDC) and Linear Imaging and Self-Scanning Sensor (LISS) datasets. Compared to alternative methods, the trial outcomes showed that the suggested technique has the potential to help the radiologist make an accurate and efficient early lung cancer diagnosis. The performance of the proposed ML-CNN was analyzed using Python, where the accuracy (2.5-10.5%) was high when compared to the number of instances, precision (2.3-9.5%) was high when compared to the number of instances, sensitivity (2.4-12.5%) was high when compared to several instances, the F-score (2-30%) was high when compared to the number of cases, the error rate (0.7-11.5%) was low compared to the number of cases, and the computation time (170 ms to 400 ms) was low compared to how many cases were computed for the proposed work, including previous known methods. The proposed ML-CNN architecture shows that this technique outperforms previous works.

Convolutional neural network-based classification and monitoring models for lung cancer detection: 3D perspective approach.

Recent developments in technology and research have offered a wide variety of new techniques for image and data analysis within the medical field. Medical research helps doctors and researchers acquire not only knowledge about health and new diseases, but also techniques of prevention and treatment. In particular, radiomic analysis is mainly used to extract quantitative data from medical images and to build a model strong enough to diagnose focal diseases. However, finding a model capable to fit all patient situations is not an easy task. In this paper frame prediction models and classification models are reported in order to predict the evolution of a given data series and determine whether an anomaly exists or not. This article also shows how to build and make use of a convolutional neural network-based architecture aiming to accomplish prediction task for medical images, not only using common computer tomography scans, but also 3D volumes.

Terahertz meta-biosensor based on high-Q electrical resonance enhanced by the interference of toroidal dipole.

Electrical dipole resonances typically have low Q factor and broad resonant linewidth caused by strong free-space coupling with high radiative loss. Here, we present a strategy for enhancing the Q factor of the electrical resonance via the interference of a toroidal dipole. To validate such a strategy, a metasurface consisting of two resonators is designed that responsible to the electric and toroidal dipoles. According to constructive and destructive hybridizations of the two dipole modes, enhanced and decreased Q factors are found respectively for the two hybrid modes, compared to the one for the conventional electric dipole resonance. As a practical application of such high Q resonance, we further experimentally investigate the sensing performance of the metasurface biosensor by detecting the cell concentration of lung cancer cells (type A549). Moreover, through monitoring both resonance frequency and amplitude variation of the metasurface biosensor, the dielectric permittivity of the lung cancer cells is delicately estimated by the conjoint analysis of both simulated and measured results. Our proposed metasurface paves a promising way for the study of multipole interference in the field of nanophotonics and validates its effectiveness in biomedical sensing.

Microfluidic-based exosome isolation and highly sensitive aptamer exosome membrane protein detection for lung cancer diagnosis.

Non-invasive methods of detecting cancer by circulating exosomes are challenged by inefficient purification and identification. This study hereby proposed an automated centrifugal microfluidic disc system combined with functionalized membranes (Exo-CMDS) to isolate and enrich exosomes, which will then be processed by a novel aptamer fluorescence system (Exo-AFS) in order to detect the exosome surface proteins in an effective manner. Exo-CMDS features in highly qualified yields with optimal exosomal concentration of 5.1 × 109 particles/mL from trace amount of blood samples (<300 µL) in only 8 min, which truly accomplishes the exosome isolation and purification in one-step methods. Meanwhile, the limit of detection (LOD) of PD-L1 in Exo-AFS reaches as low as 1.58 × 105 particles/mL. In the trial of clinical samples, the diagnostic accuracy of lung cancer achieves 91% (95% CI: 79%-96%) in contrast to the exosome ELISA (area under the curve: 0.9378 versus 0.8733; 30 patients). Exo-CMDS and Exo-AFS display the precedence in the aspects of inexpensiveness, celerity, purity, sensitivity and specificity when compared with the traditional techniques. Such assays potentially grant a practicable way of detecting inchoate cancers and guiding immunotherapy in clinic.

An Effective Method for Lung Cancer Diagnosis from CT Scan Using Deep Learning-Based Support Vector Network.

The diagnosis of early-stage lung cancer is challenging due to its asymptomatic nature, especially given the repeated radiation exposure and high cost of computed tomography(CT). Examining the lung CT images to detect pulmonary nodules, especially the cell lung cancer lesions, is also tedious and prone to errors even by a specialist. This study proposes a cancer diagnostic model based on a deep learning-enabled support vector machine (SVM). The proposed computer-aided design (CAD) model identifies the physiological and pathological changes in the soft tissues of the cross-section in lung cancer lesions. The model is first trained to recognize lung cancer by measuring and comparing the selected profile values in CT images obtained from patients and control patients at their diagnosis. Then, the model is tested and validated using the CT scans of both patients and control patients that are not shown in the training phase. The study investigates 888 annotated CT scans from the publicly available LIDC/IDRI database. The proposed deep learning-assisted SVM-based model yields 94% accuracy for pulmonary nodule detection representing early-stage lung cancer. It is found superior to other existing methods including complex deep learning, simple machine learning, and the hybrid techniques used on lung CT images for nodule detection. Experimental results demonstrate that the proposed approach can greatly assist radiologists in detecting early lung cancer and facilitating the timely management of patients.

Results of 10-year mobile low-dose computed tomography screenings for lung cancer in Shimane, Japan.

BACKGROUND: Some randomized controlled trials have evaluated the effects of low-dose computed tomography (CT) screening on lung cancer mortality in heavy smokers. Based on the results of those trials, our CT screening program recommended screening for people aged ≥40 years with a history of smoking. This retrospective study aimed to verify the validity of our CT screening program and elucidate the current state of CT screening program. METHODS: We retrospectively examined lung cancer detection in 25,189 participants who underwent chest CT screening by a mobile low-dose CT screening unit in the 10-year period from April 2009 to March 2019. Participants were recruited at Japan Agricultural Cooperatives (JA) Shimane Kouseiren. Participants requested CT screening for lung cancer. CT images were read by two pulmonologists. RESULTS: Lung cancer was identified in 82 of the 25,189 participants over 10 years, an overall lung cancer detection rate (percentage of lung cancers detected among all participants) of 0.33%. Lung cancer among never smokers accounted for 54.9% of the detected cases. The lung cancer detection rate was similar for smokers versus never smokers. The stage IA detection rate (percentage of stage IA lung cancers among all lung cancers detected) was 62%, while the stage Ⅳ detection rate was 10%. CONCLUSIONS: Chest CT detected lung cancer in never smokers as well as current or former smokers. Our CT screening program was not effective for never smokers; thus, further study of the effectiveness of CT screening in never smokers is needed.

Characteristics of expert search behavior in volumetric medical image interpretation.

Purpose: Experienced radiologists have enhanced global processing ability relative to novices, allowing experts to rapidly detect medical abnormalities without performing an exhaustive search. However, evidence for global processing models is primarily limited to two-dimensional image interpretation, and it is unclear whether these findings generalize to volumetric images, which are widely used in clinical practice. We examined whether radiologists searching volumetric images use methods consistent with global processing models of expertise. In addition, we investigated whether search strategy (scanning/drilling) differs with experience level. Approach: Fifty radiologists with a wide range of experience evaluated chest computed-tomography scans for lung nodules while their eye movements and scrolling behaviors were tracked. Multiple linear regressions were used to determine: (1) how search behaviors differed with years of experience and the number of chest CTs evaluated per week and (2) which search behaviors predicted better performance. Results: Contrary to global processing models based on 2D images, experience was unrelated to measures of global processing (saccadic amplitude, coverage, time to first fixation, search time, and depth passes) in this task. Drilling behavior was associated with better accuracy than scanning behavior when controlling for observer experience. Greater image coverage was a strong predictor of task accuracy. Conclusions: Global processing ability may play a relatively small role in volumetric image interpretation, where global scene statistics are not available to radiologists in a single glance. Rather, in volumetric images, it may be more important to engage in search strategies that support a more thorough search of the image.

An Integration of blockchain and AI for secure data sharing and detection of CT images for the hospitals.

Deep learning, for image data processing, has been widely used to solve a variety of problems related to medical practices. However, researchers are constantly struggling to introduce ever efficient classification models. Recent studies show that deep learning can perform better and generalize well when trained using a large amount of data. Organizations such as hospitals, testing labs, research centers, etc. can share their data and collaboratively build a better learning model. Every organization wants to retain the privacy of their data, while on the other hand, these organizations want accurate and efficient learning models for various applications. The concern for privacy in medical data limits the sharing of data among multiple organizations due to some ethical and legal issues. To retain privacy and enable data sharing, we present a unique method that combines locally learned deep learning models over the blockchain to improve the prediction of lung cancer in health-care systems by filling the defined gap. There are several challenges involved in sharing that data while maintaining privacy. In this paper, we identify and address such challenges. The contribution of our work is four-fold: (i) We propose a method to secure medical data by only sharing the weights of the trained deep learning model via smart contract. (ii) To deal with different sized computed tomography (CT) images from various sources, we adopted the Bat algorithm and data augmentation to reduce the noise and overfitting for the global learning model. (iii) We distribute the local deep learning model wights to the blockchain decentralized network to train a global model. iv) We propose a recurrent convolutional neural network (RCNN) to estimate the region of interest (ROI) in theCT images. An extensive empirical study has been conducted to verify the significance of our proposed method for better prediction of cancer in the early stage. Experimental results of the proposed model can show that our proposed technique can detect the lung cancer nodules and also achieve better performance.

Lung Cancer Detection and Improving Accuracy Using Linear Subspace Image Classification Algorithm.

The ability to identify lung cancer at an early stage is critical, because it can help patients live longer. However, predicting the affected area while diagnosing cancer is a huge challenge. An intelligent computer-aided diagnostic system can be utilized to detect and diagnose lung cancer by detecting the damaged region. The suggested Linear Subspace Image Classification Algorithm (LSICA) approach classifies images in a linear subspace. This methodology is used to accurately identify the damaged region, and it involves three steps: image enhancement, segmentation, and classification. The spatial image clustering technique is used to quickly segment and identify the impacted area in the image. LSICA is utilized to determine the accuracy value of the affected region for classification purposes. Therefore, a lung cancer detection system with classification-dependent image processing is used for lung cancer CT imaging. Therefore, a new method to overcome these deficiencies of the process for detection using LSICA is proposed in this work on lung cancer. MATLAB has been used in all programs. A proposed system designed to easily identify the affected region with help of the classification technique to enhance and get more accurate results.